Related references
Note: Only part of the references are listed.Urothelial cancer harbours EGFR and HER2 amplifications and exon 20 insertions
Russell W. Madison et al.
BJU INTERNATIONAL (2020)
Comprehensive Assessment of Immuno-oncology Biomarkers in Adenocarcinoma, Urothelial Carcinoma, and Squamous-cell Carcinoma of the Bladder
Andrea Necchi et al.
EUROPEAN UROLOGY (2020)
Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts
Kwanghee Kim et al.
NATURE COMMUNICATIONS (2020)
Molecular Characterization of Upper Tract Urothelial Carcinoma in the Era of Next-generation Sequencing: A Systematic Review of the Current Literature
Melanie R. Hassler et al.
EUROPEAN UROLOGY (2020)
Lynch syndrome and urologic malignancies: a contemporary review
Amy Lim et al.
CURRENT OPINION IN UROLOGY (2019)
Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma
Emil Christensen et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma
Y. Loriot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling
Brian D. Robinson et al.
NATURE COMMUNICATIONS (2019)
A Novel Next-Generation Sequencing Approach to Detecting Microsatellite Instability and Pan-Tumor Characterization of 1000 Microsatellite Instability-High Cases in 67,000 Patient Samples
Sally E. Trabucco et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Mutational Analysis of 472 Urothelial Carcinoma Across Grades and Anatomic Sites
Amin H. Nassar et al.
CLINICAL CANCER RESEARCH (2019)
Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma
Francois Audenet et al.
CLINICAL CANCER RESEARCH (2019)
Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
Simon Vyse et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update
Morgan Roupret et al.
EUROPEAN UROLOGY (2018)
Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers
Min Yuen Teo et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Analytical Validation of a Hybrid Capture-Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA
Travis A. Clark et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2018)
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
J. Mateo et al.
ANNALS OF ONCOLOGY (2018)
Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab
David R. Gandara et al.
NATURE MEDICINE (2018)
Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma
Tyler J. Moss et al.
EUROPEAN UROLOGY (2017)
Optimizing management of upper tract urothelial carcinoma
Matthew T. Campbell et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers et al.
GENOME MEDICINE (2017)
Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer
Gillian Vandekerkhove et al.
CLINICAL CANCER RESEARCH (2017)
A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naive Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer
David J. McConkey et al.
EUROPEAN UROLOGY (2016)
Genomic Characterization of Upper Tract Urothelial Carcinoma
John P. Sfakianos et al.
EUROPEAN UROLOGY (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Molecular Analysis of Upper Tract and Bladder Urothelial Carcinoma: Results from a Microarray Comparison
Thomas Sanford et al.
PLOS ONE (2015)
Comprehensive molecular characterization of urothelial bladder carcinoma
John N. Weinstein et al.
NATURE (2014)
Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate Twins
David A. Green et al.
JOURNAL OF UROLOGY (2013)
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
Garrett M. Frampton et al.
NATURE BIOTECHNOLOGY (2013)
Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma
JWF Catto et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Microsatellite instability in urothelial carcinoma of the upper urinary tract
N Amira et al.
JOURNAL OF UROLOGY (2003)
Upper tract urothelial neoplasms: Incidence and survival during the last 2 decades
JJ Munoz et al.
JOURNAL OF UROLOGY (2000)
Share Paper
